-
2
-
-
62549106168
-
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary
-
Sant M, Allemani C, Santiaquilani M et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-991.
-
(2009)
Eur J Cancer
, vol.45
, pp. 931-991
-
-
Sant, M.1
Allemani, C.2
Santiaquilani, M.3
-
3
-
-
33750603100
-
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
-
Govindan R, Page N, Morgensztern D et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24: 4539-4544.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4539-4544
-
-
Govindan, R.1
Page, N.2
Morgensztern, D.3
-
4
-
-
75749108918
-
Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis
-
Parsons A, Daley A, Begh R et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340: b5569.
-
(2010)
BMJ
, vol.340
-
-
Parsons, A.1
Daley, A.2
Begh, R.3
-
5
-
-
79953008247
-
Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers
-
Cuffe S, Moua T, Summerfield R et al. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol 2011; 6: 818-822.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 818-822
-
-
Cuffe, S.1
Moua, T.2
Summerfield, R.3
-
6
-
-
78651424752
-
Seventh edition of cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams
-
Lababede O, Meziane M, Rice T. Seventh edition of cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams. Chest 2011; 139: 183-189.
-
(2011)
Chest
, vol.139
, pp. 183-189
-
-
Lababede, O.1
Meziane, M.2
Rice, T.3
-
7
-
-
37349068491
-
The International Association for the study of lung cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer
-
Shepherd FA, Crowley J, Van Houtte P et al. The International Association for the study of lung cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007; 2: 1067-1077.
-
(2007)
J Thorac Oncol
, vol.2
, pp. 1067-1077
-
-
Shepherd, F.A.1
Crowley, J.2
Van Houtte, P.3
-
8
-
-
79960037440
-
The role of positron emission tomography in management of small cell lung cancer
-
Thomson D, Hulse P, Lorigan P et al. The role of positron emission tomography in management of small cell lung cancer. Lung Cancer 2011; 73: 121-126.
-
(2011)
Lung Cancer
, vol.73
, pp. 121-126
-
-
Thomson, D.1
Hulse, P.2
Lorigan, P.3
-
10
-
-
0033611522
-
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
-
Turrisi AT, 3rd, Kim K, Blum R et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999; 340: 265-271.
-
(1999)
N Engl J Med
, vol.340
, pp. 265-271
-
-
Turrisi, A.T.3rd.1
Kim, K.2
Blum, R.3
-
11
-
-
77649142718
-
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer
-
Yu JB, Decker RH, Detterbeck FC et al. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010; 5: 215-219.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 215-219
-
-
Yu, J.B.1
Decker, R.H.2
Detterbeck, F.C.3
-
12
-
-
77149147774
-
Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
-
Schreiber D, Rineer J, Weedon J et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated? Cancer 2010; 116: 1350-1357.
-
(2010)
Cancer
, vol.116
, pp. 1350-1357
-
-
Schreiber, D.1
Rineer, J.2
Weedon, J.3
-
13
-
-
84875263209
-
Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer
-
Reymen B, Van Loon J, van Baardwijk A et al. Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer. Int J Radiat Oncol Biol Phys 2013; 85: 1319-1324.
-
(2013)
Int J Radiat Oncol Biol Phys
, vol.85
, pp. 1319-1324
-
-
Reymen, B.1
Van Loon, J.2
van Baardwijk, A.3
-
14
-
-
16244389133
-
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
-
Fried DB, Morris DE, Poole C et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004; 22: 4837-4845.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4837-4845
-
-
Fried, D.B.1
Morris, D.E.2
Poole, C.3
-
15
-
-
34548206333
-
Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
-
Pijls-Johannesma M, De Ruysscher D, Vansteenkiste J et al. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials. Cancer Treat Rev 2007; 33: 461-473.
-
(2007)
Cancer Treat Rev
, vol.33
, pp. 461-473
-
-
Pijls-Johannesma, M.1
De Ruysscher, D.2
Vansteenkiste, J.3
-
16
-
-
33644991074
-
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
-
De Ruysscher D, Pijls-Johannesma M, Bentzen SM et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006; 24: 1057-1063.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1057-1063
-
-
De Ruysscher, D.1
Pijls-Johannesma, M.2
Bentzen, S.M.3
-
17
-
-
20744445704
-
Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial
-
Blackstock AW, Bogart JA, Matthews C et al. Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial. Clin Lung Cancer 2005; 6: 287-292.
-
(2005)
Clin Lung Cancer
, vol.6
, pp. 287-292
-
-
Blackstock, A.W.1
Bogart, J.A.2
Matthews, C.3
-
18
-
-
84881233811
-
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer
-
Sun JM, Ahn YC, Choi EK et al. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer. Ann Oncol 2013; 24: 2088-2092.
-
(2013)
Ann Oncol
, vol.24
, pp. 2088-2092
-
-
Sun, J.M.1
Ahn, Y.C.2
Choi, E.K.3
-
19
-
-
77951865740
-
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study
-
van Loon J, De Ruysscher D, Wanders R et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2010; 77: 329-336.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.77
, pp. 329-336
-
-
van Loon, J.1
De Ruysscher, D.2
Wanders, R.3
-
20
-
-
83955161774
-
Positron emission tomography/ computed tomography-guided intensity-modulated radiotherapy for limitedstage small-cell lung cancer
-
Shirvani SM, Komaki R, Heymach JV et al. Positron emission tomography/ computed tomography-guided intensity-modulated radiotherapy for limitedstage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012; 82: e91-e97.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
-
-
Shirvani, S.M.1
Komaki, R.2
Heymach, J.V.3
-
21
-
-
79955494691
-
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
-
Le Péchoux C, Laplanche A, Faivre-Finn C et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol 2011; 22: 1154-1163.
-
(2011)
Ann Oncol
, vol.22
, pp. 1154-1163
-
-
Le Péchoux, C.1
Laplanche, A.2
Faivre-Finn, C.3
-
22
-
-
79961127734
-
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer
-
Wolfson AH, Bae K, Komak R et al. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011; 81: 77-84.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. 77-84
-
-
Wolfson, A.H.1
Bae, K.2
Komak, R.3
-
23
-
-
79952408951
-
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials
-
Foster NR, Qi Y, Shi Q et al. Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials. Cancer 2011; 117: 1262-1271.
-
(2011)
Cancer
, vol.117
, pp. 1262-1271
-
-
Foster, N.R.1
Qi, Y.2
Shi, Q.3
-
24
-
-
84863752868
-
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
-
Rossi A, Di Maio M, Chiodini P et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012; 30: 1692-1698.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1692-1698
-
-
Rossi, A.1
Di Maio, M.2
Chiodini, P.3
-
25
-
-
0034129381
-
Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatincontaining regimen versus a regimen without this alkylating agent
-
Pujol JL, Carestia L, Daurès JP. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatincontaining regimen versus a regimen without this alkylating agent. Br J Cancer 2000; 83: 8-15.
-
(2000)
Br J Cancer
, vol.83
, pp. 8-15
-
-
Pujol, J.L.1
Carestia, L.2
Daurès, J.P.3
-
26
-
-
0033797356
-
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
-
Mascaux C, Paesmans M, Berghmans T et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000; 30: 23-26.
-
(2000)
Lung Cancer
, vol.30
, pp. 23-26
-
-
Mascaux, C.1
Paesmans, M.2
Berghmans, T.3
-
27
-
-
15944375520
-
Chemotherapy strategies in the treatment of small cell lung cancer
-
Popat S, O'Brien M. Chemotherapy strategies in the treatment of small cell lung cancer. Anticancer Drugs 2005; 16: 361-372.
-
(2005)
Anticancer Drugs
, vol.16
, pp. 361-372
-
-
Popat, S.1
O'Brien, M.2
-
28
-
-
84858322703
-
An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer
-
Shao N, Jin S, Zhu W. An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. J Thorac Oncol 2012; 7: 470-472.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 470-472
-
-
Shao, N.1
Jin, S.2
Zhu, W.3
-
29
-
-
66349102227
-
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124
-
Lara PN, Jr, Natale R, Crowley J et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009; 27: 2530-2535.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2530-2535
-
-
Lara Jr., P.N.1
Natale, R.2
Crowley, J.3
-
30
-
-
77953239393
-
A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
-
Zatloukal P, Cardenal F, Szczesna A et al. A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease. Ann Oncol 2010; 21: 1810-1816.
-
(2010)
Ann Oncol
, vol.21
, pp. 1810-1816
-
-
Zatloukal, P.1
Cardenal, F.2
Szczesna, A.3
-
31
-
-
84865687132
-
Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease smallcell lung cancer: final results of a randomized phase III trial
-
Fink TH, Huber RM, Heigener DF et al. Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease smallcell lung cancer: final results of a randomized phase III trial. J Thorac Oncol 2012; 7: 1432-1439.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 1432-1439
-
-
Fink, T.H.1
Huber, R.M.2
Heigener, D.F.3
-
32
-
-
33646445762
-
Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer
-
Eckardt JR, von Pawel J, Papai Z et al. Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer. J Clin Oncol 2006; 24: 2044-2051.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2044-2051
-
-
Eckardt, J.R.1
von Pawel, J.2
Papai, Z.3
-
33
-
-
58349115184
-
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer
-
Lee SM, James LE, Qian W et al. Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. Thorax 2009; 64: 75-80.
-
(2009)
Thorax
, vol.64
, pp. 75-80
-
-
Lee, S.M.1
James, L.E.2
Qian, W.3
-
34
-
-
77957020019
-
Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis
-
Rossi A, Garassino MC, Cinquini M et al. Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis. Lung Cancer 2010; 70: 119-128.
-
(2010)
Lung Cancer
, vol.70
, pp. 119-128
-
-
Rossi, A.1
Garassino, M.C.2
Cinquini, M.3
-
35
-
-
29144480913
-
Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A meta-analysis of the published controlled trials
-
Bozcuk H, Artac M, Ozdogan M et al. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A meta-analysis of the published controlled trials. Cancer 2005; 104: 2650-2657.
-
(2005)
Cancer
, vol.104
, pp. 2650-2657
-
-
Bozcuk, H.1
Artac, M.2
Ozdogan, M.3
-
36
-
-
34547937885
-
Prophylactic cranial irradiation in small-cell lung cancer
-
Slotman BJ, Faivre-Finn C, Kramer GW et al. Prophylactic cranial irradiation in small-cell lung cancer. N Engl J Med 2007; 357: 664-672.
-
(2007)
N Engl J Med
, vol.357
, pp. 664-672
-
-
Slotman, B.J.1
Faivre-Finn, C.2
Kramer, G.W.3
-
37
-
-
58149346191
-
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups
-
Slotman BJ, Mauer ME, Bottomley A et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol 2009; 27: 78-84.
-
(2009)
J Clin Oncol
, vol.27
, pp. 78-84
-
-
Slotman, B.J.1
Mauer, M.E.2
Bottomley, A.3
-
38
-
-
0033016449
-
Role of radiation therapy in the combinedmodality treatment of patients with extensive disease small-cell lung cancer: a randomized study
-
Jeremic B, Shibamoto Y, Nikolic N et al. Role of radiation therapy in the combinedmodality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 1999; 17: 2092-2099.
-
(1999)
J Clin Oncol
, vol.17
, pp. 2092-2099
-
-
Jeremic, B.1
Shibamoto, Y.2
Nikolic, N.3
-
39
-
-
34247218552
-
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
-
O'Brien ME, Ciuleanu TE, Tsekov H et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 2006; 24: 5441-5447.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5441-5447
-
-
O'Brien, M.E.1
Ciuleanu, T.E.2
Tsekov, H.3
-
40
-
-
0033044111
-
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer
-
von Pawel J, Schiller JH, Shepherd FA et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 1999; 1 and 427: 658-667.
-
(1999)
J Clin Oncol
, vol.1
, pp. 658-667
-
-
von Pawel, J.1
Schiller, J.H.2
Shepherd, F.A.3
-
41
-
-
34249941781
-
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer
-
Eckardt JR, von Pawel J, Pujol JL et al. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. Clin Oncol 2007; 25: 2086-2092.
-
(2007)
Clin Oncol
, vol.25
, pp. 2086-2092
-
-
Eckardt, J.R.1
von Pawel, J.2
Pujol, J.L.3
-
42
-
-
80051845520
-
Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC)
-
abstr 7000
-
Jotte R, Von Pawel J, Spigel D et al. Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC). J Clin Oncol 2012; 29 (Suppl.): abstr 7000.
-
(2012)
J Clin Oncol
, vol.29
, Issue.SUPPL.
-
-
Jotte, R.1
Von Pawel, J.2
Spigel, D.3
-
43
-
-
38649126178
-
Effectiveness of intensive follow-up after response in patients with small cell lung cancer
-
Sugiyama T, Hirose T, Hosaka T et al. Effectiveness of intensive follow-up after response in patients with small cell lung cancer. Lung Cancer 2008; 59: 255-261.
-
(2008)
Lung Cancer
, vol.59
, pp. 255-261
-
-
Sugiyama, T.1
Hirose, T.2
Hosaka, T.3
|